Table 1

Baseline patient characteristics

Age (yrs)Median63
Range32–81
SexMale17
Female5
Karnofsky performance status90%3
80%11
70%5
60%3
Prior therapySurgery+ XRTa10
Chemo+ XRT4
Surgery+ XRT+ Chemo4
Radiotherapy alone2
Surgery alone1
None1
Location of recurrenceCervical10
Supraclavicular2
Facial2
Tongue2
Oral2
Other4
Tumor size (cm2)Median11.8
Range2.2–20
p53 gene sequence (exons 4–9)Mutant16
Wild type5
Noninterpretable1
Baseline neutralizing antibody levelsPositive13
Negative9
CD4 counts (range, 152–1050)<50019
>5003
  • a XRT, radiotherapy; Chemo, chemotherapy.